Number of items at this level: 58.
Amin Al Olama, A., Kote-Jarai, Z., Schumacher, F. R., Wiklund, F., Berndt, S. I., Benlloch, S., et al.
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
Human Molecular Genetics, 22(2), pp. 408-415.
Antony, Joyce, Gopalan, Vinod, Smith, Robert A., & Lam, Alfred King-Yin
Carcinoma ex pleomorphic adenoma : a comprehensive review of clinical, pathological and molecular data.
Head and Neck Pathology, 6(1), pp. 1-9.
Becker-Santos, Daiana D., Guo, Yubin, Ghaffari, Mazyar, Vickers, Elaine D., Lehman, Melanie, Altamirano-Dimas, Manuel, et al.
Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models.
Carcinogenesis, 33(12), pp. 2558-2567.
Betsou, Fotini, Gunter, Elaine, Clements, Judith, DeSouza, Yvonne, Goddard, Katrina A.B., Guadagni, Fiorella, et al.
Identification of evidence-based biospecimen quality-control tools.
The Journal of Molecular Diagnostics, 15(1), pp. 3-16.
Byron, Sara A., Gartside, Michael, Powell, Matthew A., Wellens, Candice L., Gao, Feng, Mutch, David G., et al.
FGFR2 point mutations in 466 Endometrioid Endometrial Tumors : relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and Clinicopathological features.
PLoS ONE, 7(2), e30801-e30801.
Chambers, Karen F. , Bacon, James R., Kemsley, E. Katherine, Mills, Robert D., Ball, Richard Y., Mithen, Richard F., et al.
Gene expression profile of primary prostate epithelial and stromal cells in response to sulforaphane or iberin exposure.
The Prostate, 69(13), pp. 1411-1421.
Conway, Thomas, Wazny, Jeremy, Bromage, Andrew, Tymms, Martin, Sooraj, Dhanya, Williams, Elizabeth D., et al.
Xenome--a tool for classifying reads from xenograft samples.
Bioinformatics, 28(12), i172-i178.
Dutton-Regester, Ken, Aoude, Lauren G., Nancarrow, Derek J., Stark, Mitchell S., O'Connor, Linda, Lanagan, Cathy, et al.
Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene.
Genes Chromosomes Cancer, 51(5), pp. 452-461.
Dutton-Regester, Ken, Irwin, Darryl, Hunt, Priscilla, Aoude, Lauren G., Tembe, Varsha, Pupo, Gulietta M., et al.
A high-throughput panel for identifying clinically relevant mutation profiles in melanoma.
Molecular Cancer Therapeutics, 11(4), pp. 888-897.
Freeman, Lisa M., Lam, Alfred King-Yin, Petcu, Eugene, Smith, Robert A., Salajegheh, Ali, Diamond, Peter, et al.
Myeloma-induced alloreactive T cells arising in myeloma-infiltrated bones include double-positive CD8+CD4+ T cells : evidence from myeloma-bearing mouse model.
The Journal of Immunology, 187(8), pp. 3987-3996.
Gopalan, Vinod, Pillai, Suja, Ebrahimi, Faeza, Salajegheh, Ali, Lam, Tommy C., Le, Tran K., et al.
Regulation of microRNA-1288 in colorectal cancer : altered expression and its clinicopathological significance.
Molecular Carcinogenesis, 53 (S1), E36-E44.
Gopalan, Vinod, Smith, Robert A., Nassiri, Mohammad, Yasuda, Koichi, Salajegheh, Ali, Kim, Sang Y., et al.
GAEC1 and colorectal cancer : a study of the relationships between a novel oncogene and clinicopathologic features.
Human Pathology, 41(7), pp. 1009-1015.
Gopalan, Vinod, Yasuda, Koichi, Pillai, Suja, Tiang, Thomas, Leung, Melissa, Lu, Cu-Tai, et al.
Gene amplified in oesophageal cancer 1 (GAEC1) amplification in colorectal cancers and its impact on patient's survival.
Journal of Clinical Pathology, 66(8), pp. 721-723.
Irani, Soussan, Salajegheh, Ali, Gopalan, Vinod, Smith, Robert A., & Lam, Alfred King-Yin
Expression profile of endothelin 1 and its receptor endothelin receptor A in papillary thyroid carcinoma and their correlations with clinicopathologic characteristics.
Annals of Diagnostic Pathology, 18(2), pp. 43-48.
Jeet, Varinder, Tevz, Gregor, Lehman, Melanie, Hollier, Brett, & Nelson, Colleen
Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells.
Endocrine Related Cancer, 21, pp. 723-737.
Kasem, Kais, Gopalan, Vinod, Salajegheh, Ali, Lu, Cu-Tai, Smith, Robert A., & Lam, Alfred King-Yin
JK1 (FAM134B) gene and colorectal cancer : a pilot study on the gene copy number alterations and correlations with clinicopathological parameters.
Experimental and Molecular Pathology, 97(1), pp. 31-36.
Kasem, Kais, Gopalan, Vinod, Salajegheh, Ali, Lu, Cu-Tai, Smith, Robert A., & Lam, Alfred King-Yin
The roles of JK-1 (FAM134B) expressions in colorectal cancer.
Experimental Cell Research, 326(1), pp. 166-173.
Kasem, Kais, Sullivan, Emily, Gopalan, Vinod, Salajegheh, Ali, Smith, Robert A., & Lam, Alfred King-Yin
JK1 (FAM134B) represses cell migration in colon cancer : a functional study of a novel gene.
Experimental and Molecular Pathology, 97(1), pp. 99-104.
Krauthammer, Michael, Kong, Yong, Ha, Byung Hak, Evans, Perry, Bacchiocchi, Antonella, McCusker, James P, et al.
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.
Nature Genetics, 44(9), pp. 1006-1014.
Kwan, Pak Shing, Lau, Chi Chiu, Chiu, Yung Tuen, Man, Cornelia, Liu, Ji, Tang, Kai Dun, et al.
Daxx regulates mitotic progression and prostate cancer predisposition.
Carcinogenesis, 34(4), pp. 750-759.
Lai, John, An, Jiyuan, Nelson, Colleen C., Lehman, Melanie L., Batra, Jyotsna, & Clements, Judith A.
Analysis of androgen and anti-androgen regulation of KLK-related peptidase 2, 3, and 4 alternative transcripts in prostate cancer.
Biological Chemistry, 395(9), pp. 1127-1132.
Lam, Alfred King-Yin, Gopalan, Vinod, Nassiri, Mohammad, Kasim, Kais, Dissanayake, Jayampathy, Tang, Johnny Chuek-on, et al.
Altered JS-2 expression in colorectal cancers and its clinical pathological relevance.
Molecular Oncology, 5(5), pp. 475-481.
Long, Jirong, Zheng, Wei, Xiang, Yong-Bing, Lose, Felicity, Thompson, Deborah, Tomlinson, Ian, et al.
Genome-wide association study identifies a possible susceptibility locus for endometrial cancer.
Cancer Epidemiology, Biomarkers & Prevention, 21(6), pp. 980-987.
Lose, Felicity, Lawrence, Mitchell Graham, Srinivasan, Srilakshmi, O'Mara, Tracy, Marquart, Louise, Chambers, Suzanne, et al.
Kallikrein 14 is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressiveness.
Biological Chemistry, 393(5), pp. 403-412.
Morris, Christelle, Tomimatsu, Nozomi , Richard, Derek J., Cluet, David, Burma, Sandeep, Khanna, Kum Kum , et al.
INT6/EIF3E interacts with ATM and is required for proper execution of the DNA damage response in human cells.
Cancer Research, 72(8), pp. 2006-2016.
O’Flaherty, John D., Barr, Martin, Fennell, Dean, Richard, Derek, Reynolds, John, O’Leary, John, et al.
The cancer stem-cell hypothesis : its emerging role in lung cancer biology and its relevance for future therapy.
Journal of Thoracic Oncology, 7(12), pp. 1880-1890.
Qiao, B., Gopalan, V., Chen, Z., Smith, Robert A., Tao, Q., & Lam, A. K.
Epithelial-mesenchymal transition and mesenchymal-epithelial transition are essential for the acquisition of stem cell properties in hTERT-immortalised oral epithelial cells.
Biology of the cell, 104(8), pp. 476-489.
Rahman, Md Atiqur, Salajegheh, Ali, Smith, Robert A., & Lam, Alfred King-yin
BRAF inhibitor therapy for melanoma, thyroid and colorectal cancers : development of resistance and future prospects.
Current Cancer Drug Targets, 14(2), pp. 128-143.
Ricciardelli, Carmela, Frewin, Kate M., Tan, Izza de Arao, Williams, Elizabeth D., Opeskin, Kenneth, Pritchard, Melanie A., et al.
The ADAMTS1 protease gene is required for mammary tumor growth and metastasis.
The American Journal of Pathology, 179(6), pp. 3075-3085.
Said, Nur Akmarina B.M., Gould, Cathryn M., Lackovic, Kurt, Simpson, Kaylene J., & Williams, Elizabeth D.
Whole-genome multiparametric screening to identify modulators of epithelial-to-mesenchymal transition.
ASSAY and Drug Development Technologies, 12(7), pp. 385-394.
Salajegheh, Ali, Dolan-Evans, Elliot, Sullivan, Emily, Irani, Soussan, Rahman, Md Atiqur, Vosgha, Haleh, et al.
The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression.
Experimental and Molecular Pathology, 96(2), pp. 212-218.
Salajegheh, Ali, Pakneshan, Sahar, Rahman, Atiqur, Dolan-Evans, Elliot, Zhang, Sheldon, Kwong, Esther, et al.
Co-regulatory potential of vascular endothelial growth factor–A and vascular endothelial growth factor–C in thyroid carcinoma.
Human pathology, 44(10), pp. 2204-2212.
Salajegheh, Ali, Smith, Robert A., Kasem, Kais, Gopalan, Vinod, Nassiri, Mohammad, Williams, Richard, et al.
Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: Potential markers for aggressive phenotypes.
European Journal of Surgical Oncology, 37(1), pp. 93-99.
Saunders, Edward J., Dadaev, Tokhir, Leongamornlert, Daniel A., Jugurnauth-Little, Sarah, Tymrakiewicz, Malgorzata, Wiklund, Fredrik, et al.
Fine-mapping the HOXB region detects common variants tagging a rare coding allele : evidence for synthetic association in prostate cancer.
PLoS Genetics, 10(2), e1004129.
Seim, Inge, Jeffery, Penny L., de Amorim, Laura Miranda, Walpole, Carina M., Fung, Jenny, Whiteside, Eliza, et al.
Ghrelin O-acyltransferase (GOAT) is expressed in prostate cancer tissues and cell lines and expression is differentially regulated in vitro by ghrelin.
Reproductive Biology and Endocrinology, 11(70).
Seim, Inge, Lubik, Amy A., Lehman, Melanie, Tomlinson, Nadine, Whiteside, Eliza, Herington, Adrian C., et al.
Cloning of a novel insulin-regulated ghrelin transcript in prostate cancer.
Journal of Molecular Endocrinology.
Smith, Robert A., Salajegheh, Ali, Weinstein, Stephen R., Nassiri, Mohammad, & Lam, Alfred King-Yin
Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant.
Human Pathology, 42(4), pp. 500-506.
Speer, Runa, Wulfkuhle, Julia, Espina, Virginia, Aurajo, Robyn, Edmiston, Kirsten H., Liotta, Lance, et al.
Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy.
Cancer Genomics and Proteomics, 4(3), pp. 157-164.
Terzian, Tamara, Torchia, Enrique C., Dai, Daisy, Robinson, Steven E., Murao, Kazutoshi, Stiegmann, Regan A., et al.
p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation.
Pigment Cell and Melanoma Research, 23(6), pp. 781-794.
White-Al Habeeb, Nicole M.A., Linh, T. Ho, Olkhov-Mitsel, Ekaterina, Kron, Ken, Pethe, Vaijayanti, Lehman, Melanie, et al.
Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer.
Mertens-Walker, I., Fernandini, B.C., Rockstroh, A., Nelson, C.C., Herington, A.C., & Stephenson, S.A.
Analysis of gene expression influenced by EphB4 identifies integrin β 8 as simultaneously regulated in prostate cancer cells. In
67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand (USANZ 2014), 16–19 March 2014, Brisbane, QLD.